A deeper analysis of the distribution and frequency of used TRBV genes revealed a high usage of TRBV3, TRBV19, and TRBV12-2 + TRBV13-2 in AAA samples at days 7, 14, and 28 (Figure 3E). This evidence concerns the gene TRBV19 and triple-A syndrome.